Comparison Between MEFIB, MAST, and FAST for Detecting Significant Fibrosis in Patients With NAFLD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD
J. Hepatol. 2022 Dec 01;77(6)1482-1490, BK Kim, N Tamaki, K Imajo, M Yoneda, N Sutter, J Jung, T Lin, XM Tu, J Bergstrom, K Nguyen, L Nguyen, T Le, E Madamba, L Richards, MA Valasek, C Behling, CB Sirlin, A Nakajima, R LoombaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.